Mild encephalopathy with reversible splenial lesion in a patient with influenza A infection-first report in an adult patient in the USA

BMJ Case Reports

Volumn 2015, Issue , 2015, Pages

  Wang, Jonathan ^a   Stewart, Earl ^a   Dapaah Afriyie, Kwame ^b   Finn, Arkadiy ^c  

^a RHODE ISLAND HOSPITAL   (United States)

^b MIRIAM HOSPITAL   (United States)

^c BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BRAIN DISEASE; BRAIN RADIOGRAPHY; CASE REPORT; CLINICAL FEATURE; CORPUS CALLOSUM; DIABETES INSIPIDUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HUMAN; HYPERNATREMIA; HYPOPITUITARISM; INFLUENZA A; LABORATORY DIAGNOSIS; MALE; MIDDLE AGED; MILD ENCEPHALOPATHY WITH REVERSIBLE SPLENIAL LESION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTOPENIA; UNITED STATES; BRAIN DISEASES; COMPLICATION; INFLUENZA, HUMAN; PATHOLOGY; VIROLOGY;

ANTIVIRUS AGENT; OSELTAMIVIR;

ANTIVIRAL AGENTS; BRAIN DISEASES; CORPUS CALLOSUM; DIAGNOSIS, DIFFERENTIAL; HUMANS; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OSELTAMIVIR; PROGNOSIS;

EID: 84937057147     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr-2015-210197     Document Type: Article

References (14)

1. Hoshino A, Saitoh M, Oka A, et al. Epidemiology of acute encephalopathy in Japan, with emphasis on the association of viruses and syndromes. Brain Dev 2012;34:337-43.
2. Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med 2000;342:1493-9.
3. Cuker A. Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach. Semin Thromb Hemost 2014;40:106-14.
4. Linden K, Moser O, Simon A, et al. Transient splenial lesion in influenza A H1N1 2009 infection. Radiologe 2011;51:220-2.
5. Iwata A, Matsubara K, Nigami H, et al. Reversible splenial lesion associated with novel influenza A (H1N1) viral infection. Pediatr Neurol 2010;42:447-50.
6. Takanashi J. Two newly proposed infectious encephalitis/encephalopathy syndromes. Brain Dev 2009;31:521-8.
7. Fiore AE, Fry A, Shay D, et al. Antiviral agents for the treatment and chemoprophylaxis of influenza-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60:1-24.
8. Fluss J, Ferey S, Menache-starobinski C, et al. Mild influenza-associated encephalopathy/encephalitis with a reversible splenial lesion in a Caucasian child with additional cerebellar features. Eur J Paediatr Neurol 2010;14:97-100.
9. Bulakbasi N, Kocaoglu M, Tayfun C, et al. Transient splenial lesion of the corpus callosum in clinically mild influenza-associated encephalitis/encephalopathy. AJNR Am J Neuroradiol 2006;27:1983-6.
10. Tada H, Takanashi J, Barkovich AJ, et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology 2004;63:1854-8.
11. Kizilkilic O, Karaca S. Influenza-associated encephalitis-encephalopathy with a reversible lesion in the splenium of the corpus callosum: case report and literature review. AJNR Am J Neuroradiol 2004;25:1863-4.
12. Garcia-monco JC, Cortina IE, Ferreira E, et al. Reversible splenial lesion syndrome (RESLES): what's in a name? J Neuroimaging 2011;21:e1-14.
13. Ka A, Britton P, Troedson C, et al. Mild encephalopathy with reversible splenial lesion: an important differential of encephalitis. Eur J Paediatr Neurol 2015;19:377-82.
14. Shankar B, Narayanan R, Muralitharan P, et al. Evaluation of mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) by diffusion-weighted and diffusion tensor imaging. BMJ Case Reports 2014: published online 4 June 2014, doi:10.1136/bcr-2014-204078.